Analyst Recommendations
52.02 0.72(1.40%)07/03/2024
Halozyme Therapeutics Inc. (HALO)
Halozyme Therapeutics Inc. (HALO)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 15 |
Market Outperform | 3 |
Neutral | 2 |
Overweight | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades